glp-1 nausea law firm in kentucky attorney Patients Are Suing Over Alleged Side Effects of Weight-Loss Drugs Ozempic Lawsuit | Ohio and

On July 29, 2025, Novo cut its sales and profit outlook, citing persistent use of compounded GLP-1s, slower-than-expected market expansion, and competitiondevelopments that the complaint alleges were in direct contrast to earlier assurances

Will I still need to make lifestyle changes while using these medications

In clinical trials, 86% of non-diabetic patients receiving once-weekly semaglutide injections lost at least 5% of their body weight.[8] Ozempic : Ozempic is a once-weekly subcutaneous injection approved for patients with T2D, though it is sometimes prescribed off-label for weight loss.[9] It is used alongside diet and exercise to improve glycemic control and reduce cardiovascular risk in adults with T2D

it stands out as one of the best electrolyte powders due to its low sodium concentration and variety of flavors

Okava Pharmaceuticals, a biopharmaceutical company based in San Francisco, is expected to announce on Tuesday that it has launched a pilot study testing a GLP-1 drug in obese cats, the New York Times reports

Its Health Canada-approved for the treatment of type 2 diabetes only, though its sometimes prescribed off-label for weight loss